P95

P95 BV is an international full-service CRO specializing in vaccines and infectious disease research. Founded in Belgium in 2011 by Thomas Verstraeten, the company delivers comprehensive clinical trial management, epidemiological research, real-world evidence generation, pharmacovigilance support, data management/biostatistics, medical writing, regulatory affairs consulting and more. With over a decade of experience and more than two dozen acquisitions—including OnQ Research (South Africa), Assign DMB (Austria), and 4Clinics (France)—P95 operates globally across five continents with regional hubs serving Europe, Africa, Latin America, North America & Southeast Asia. The company’s client base includes major pharmaceutical companies such as Takeda, Pfizer & GSK. It coordinates large-scale public-private partnerships for vaccine effectiveness surveillance across Europe. As of mid–2025 it employs approximately ~300 staff worldwide with estimated annual revenues around $42 million.